Solventum Corp | SOLV - Cost Of Sales


Solventum Corp reported $971M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Cencora USD 80.77B 3.02B Sep/2025
Dexcom USD 466.9M 11M Dec/2025
Insulet USD 215.2M 19M Dec/2025
Solventum Corp USD 971M 8M Dec/2025
West Pharmaceutical Services USD 501.1M 9.2M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025